NIPH Clinical Trials Search

UMIN ID: UMIN000000503

Registered date:18/10/2006

Lung Cancer Evaluation of TS-1 Study

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedPreviously untreated stageIIIB/IV NSCLC
Date of first enrollment2006/08/01
Target sample size560
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)CBDCA+TS-1 chemotherapy CBDCA+Paclitaxel chemotherapy


Primary OutcomeOverall survival
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteria1)SVC syndrome 2)Pregnant female or sexually active males/females unwilling to use contraception during the protocol treatment 3)Concomitant serious disease 4)Symptomatic brain metastases 5)Active concomitant malignancy 6)Pleural effusion, cardiac effusion, or cardiac effusion necessiating treatment 7)Uncontrolled diabetes

Related Information


public contact
Name Shinichiro Nakamura
Address Namba Plaza Bldg.3F 1-5-7,Motomachi Naniwa-ku,Osaka556-0016 JAPAN Japan
Telephone 06-6633-7400
Affiliation West Japan Oncology Group WJOG datacenter
scientific contact
Name Kazuhiko Nakagawa
Address 377-2 Ohno-higashi, Osaka-Sayama, Osaka Japan
Telephone 072-366-0221
Affiliation Kinki University School of Medicine Department of Medical Oncology